Tarsus Pharmaceuticals
Earnings Surprise
Analysts estimated TARS earnings of $-0.10 per share this quarter (Q4). TARS's actual earnings were $-0.20 per share.
TARS EPS surprise of -106.19%Analysts estimated TARS earnings of $-0.36 per share this quarter (Q3). TARS's actual earnings were $-0.30 per share.
TARS EPS surprise of 16.06%Analysts estimated TARS earnings of $-0.41 per share this quarter (Q2). TARS's actual earnings were $-0.48 per share.
TARS EPS surprise of -17.76%Analysts estimated TARS earnings of $-0.75 per share this quarter (Q1). TARS's actual earnings were $-0.64 per share.
TARS EPS surprise of 14.12%Analysts estimated TARS earnings of $-0.76 per share this quarter (Q4). TARS's actual earnings were $-0.60 per share.
TARS EPS surprise of 20.78%Analysts estimated TARS earnings of $-0.99 per share this quarter (Q3). TARS's actual earnings were $-0.61 per share.
TARS EPS surprise of 38.51%Analysts estimated TARS earnings of $-0.94 per share this quarter (Q2). TARS's actual earnings were $-0.88 per share.
TARS EPS surprise of 6.62%Analysts estimated TARS earnings of $-1.23 per share this quarter (Q1). TARS's actual earnings were $-1.01 per share.
TARS EPS surprise of 17.81%Analysts estimated TARS earnings of $-1.39 per share this quarter (Q4). TARS's actual earnings were $-1.31 per share.
TARS EPS surprise of -5.75%